Rational design of antimicrobial peptides targeting Gram-negative bacteria.

Area of Science:

• Microbiology and Biochemistry
• Biophysics
• Drug Discovery

Background:

• Host antimicrobial peptides (AMPs) target Gram-negative bacteria but face microbial resistance.
• Evolved resistance limits the long-term effectiveness of AMPs in clinical applications.

Purpose of the Study:

• To investigate methods for enhancing the antibacterial activity of host AMPs.
• To explore strategies for overcoming evolved microbial resistance to AMPs.
• To assess the impact of chemical modifications on AMP efficacy and membrane interactions.

Main Methods:

• Experimental studies on AMP-bacterial interactions.
• Molecular dynamics simulations to analyze peptide-membrane insertion.
• Testing evolved resistant bacterial strains against modified AMP variants.

Main Results:

• Terminal carboxyl capping significantly improved membrane insertion and antibacterial activity of the P1 peptide.
• Bacterial resistance evolved against the original P1 peptide was overcome by modified P1 variants.
• Backbone capping and lysine-to-arginine substitutions restored susceptibility in resistant strains.

Conclusions:

• Chemical modifications, such as terminal capping, can enhance AMP potency and efficacy.
• Strategies involving AMP variants can effectively combat evolved microbial resistance.
• Cocktails of closely related AMPs show promise for overcoming resistance and ensuring long-term therapeutic utility.